Heard et al 1998
|
Prospective Cohort
|
533
|
France
|
2 NRTI + 1 PI
|
Heard et al 2002
|
Prospective cohort
|
168
|
France
|
2 NRTIs + 1 PI or 1 NNRTI
|
Heard et al 2006
|
Prospective cohort
|
289
|
France
|
as defined by French National Recommendations
|
Orlando et al 1999
|
Prospective cohort
|
15
|
USA
|
Undefined
|
Moore et al 2002
|
Prospective cohort
|
71
|
UK
|
Undefined
|
Dorucci et al 2001
|
Prospective cohort
|
6
|
Italy
|
NA
|
Lillo et al 2001
|
Prospective cohort
|
168
|
Italy
|
Undefined
|
Del Mistro et al 2004
|
Prospective cohort
|
201
|
Italy
|
1 PI, 2 NRTIs + NNRTI; or 3 NRTIs
|
Soncini et al 2007
|
Prospective cohort
|
101
|
Italy
|
2 NRTIs + 1 PI, or NNRTI; or 3 NRTIs
|
Sirera et al 2007
|
Retrospective cohort
|
133
|
Spain
|
2 NRTIs + 1 PI or 1 NNRTI
|
Sirera et al 2008
|
Retrospective cohort
|
127
|
Spain
|
2 NRTIs + 1 PI or 1 NNRTI
|
Ellerbrock et al 2000
|
Prospective cohort
|
328
|
USA
|
Various NRTI and NNRTI (1 or more in combination) defined by 1997 NIH guidelines or >2 PI multiple regimens defined
|
Minkoff et al 2001
|
Prospective cohort, WIHS
|
781
|
USA
| |
Ahdieh-Grant et al 2004
|
Prospective cohort, WIHS
|
312
|
USA
| |
Schuman et al 2003
|
Prospective cohort, HERS
|
774
|
USA
|
as defined by DHHS Guidelines
|
Paramsothy et al 2009
|
Prospective cohort, HERS
|
537
|
USA
|
as defined by DHHS Guidelines
|
Intl Collaboration on HIV and Cancer 2000
|
Meta-analysis of prospective studies evaluating cancer risk in HIV-infected persons
|
36
|
USA, Europe, Australia
|
NA
|
Clifford et al 2005
|
Prospective cohort
|
6
|
Switzerland
|
NA
|
Engels et al 2006
|
HIV/AIDS Cancer Match Study
|
64
|
USA
|
NA
|
Biggar et al 2007
|
HIV/AIDS Cancer Match Study
|
55
|
USA
|
NA
|
Engels et al 2008
|
HIV/AIDS Cancer Match Study
|
28
|
USA
|
NA
|
Dal Maso et al 2009
|
HIV/AIDS Cancer Match Study
|
39
|
Italy
|
NA
|